Pharming Group (Netherlands) Top Management

PHARM Stock  EUR 0.83  0.02  2.35%   
Pharming Group employs about 277 people. The company is managed by 8 executives with a total tenure of roughly 647 years, averaging almost 80.0 years of service per executive, having 34.63 employees per reported executive. Analysis of Pharming Group's management performance can provide insight into the company performance.
Bruno Giannetti  Insider
Consultant
Susanne Embleton  Insider
Investor Mang
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Pharming Group Management Team Effectiveness

The company has return on total asset (ROA) of 0.0643 % which means that it generated a profit of $0.0643 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1669 %, meaning that it generated $0.1669 on every $100 dollars invested by stockholders. Pharming Group's management efficiency ratios could be used to measure how well Pharming Group manages its routine affairs as well as how well it operates its assets and liabilities.

Pharming Group Workforce Comparison

Pharming Group NV is considered to be number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 65,394. Pharming Group adds roughly 277 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.

Pharming Group NV Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Pharming Group NV Price Series Summation is a cross summation of Pharming Group price series and its benchmark/peer.

Pharming Group Notable Stakeholders

A Pharming Group stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Pharming Group often face trade-offs trying to please all of them. Pharming Group's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Pharming Group's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.

About Pharming Group Management Performance

The success or failure of an entity such as Pharming Group NV often depends on how effective the management is. Pharming Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Pharming management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Pharming management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Pharming Group N.V., a specialty pharmaceutical company, develops and manufactures biopharmaceutical products in the United States, Europe, and internationally. Pharming Group N.V. is headquartered in Leiden, the Netherlands. PHARMING GROUP operates under Biotechnology classification in Netherlands and is traded on Amsterdam Stock Exchange. It employs 183 people.
Please note, the presentation of Pharming Group's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pharming Group's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pharming Group's management manipulating its earnings.

Pharming Group Workforce Analysis

Traditionally, organizations such as Pharming Group use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Pharming Group within its industry.

Pharming Group Manpower Efficiency

Return on Pharming Group Manpower

Revenue Per Employee605.4K
Revenue Per Executive21M
Net Income Per Employee57.7K
Net Income Per Executive2M

Complementary Tools for Pharming Stock analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Bonds Directory
Find actively traded corporate debentures issued by US companies
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities